company background image
AJANTPHARM logo

Ajanta Pharma Informe acción NSEI:AJANTPHARM

Último precio

₹2.96k

Capitalización de mercado

₹369.7b

7D

3.5%

1Y

51.2%

Actualizada

23 Nov, 2024

Datos

Finanzas de la empresa +

Ajanta Pharma Limited

Informe acción NSEI:AJANTPHARM

Capitalización de mercado: ₹369.7b

Resumen de acción AJANTPHARM

Ajanta Pharma Limited, una empresa de formulación de especialidades farmacéuticas, junto con sus filiales, desarrolla, fabrica y comercializa especialidades farmacéuticas en dosis acabadas. Saber más

Análisis fundamental de AJANTPHARM
Puntuación del snowflake
Valoración1/6
Crecimiento futuro3/6
Rendimiento pasado6/6
Salud financiera6/6
Dividendos5/6

Recompensas

Se prevé un crecimiento anual de los beneficios de 16.43%

Los beneficios aumentaron un 32.5% el pasado año

Análisis de riesgos

Historial de dividendos inestable

Venta significativa por parte de personas con información privilegiada en los últimos 3 meses


Competidores de Ajanta Pharma Limited

Ipca Laboratories

NSEI:IPCALAB

₹403.7b

Gland Pharma

NSEI:GLAND

₹289.1b

GlaxoSmithKline Pharmaceuticals

BSE:500660

₹409.1b

J. B. Chemicals & Pharmaceuticals

BSE:506943

₹269.3b

Historial de precios y rendimiento

Resumen de todos los máximos históricos, cambios y caídas de precios de Ajanta Pharma
Precios históricos de las acciones
Precio actual de la acción₹2,960.05
Máximo en las últimas 52 semanas₹3,485.00
Mínimo de 52 semanas₹1,850.25
Beta0.10
1Cambio en 1 mes-0.37%
Variación en 3 meses-4.62%
Cambio de 1 año51.18%
3Variación en 3 años112.26%
Variación en 5 años345.39%
Variación desde la OPV18,799.30%

Noticias y actualizaciones recientes

Revenue Beat: Ajanta Pharma Limited Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates

Oct 31
Revenue Beat: Ajanta Pharma Limited Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates

Here's Why Ajanta Pharma (NSE:AJANTPHARM) Has Caught The Eye Of Investors

Sep 10
Here's Why Ajanta Pharma (NSE:AJANTPHARM) Has Caught The Eye Of Investors

Recent updates

Revenue Beat: Ajanta Pharma Limited Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates

Oct 31
Revenue Beat: Ajanta Pharma Limited Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates

Here's Why Ajanta Pharma (NSE:AJANTPHARM) Has Caught The Eye Of Investors

Sep 10
Here's Why Ajanta Pharma (NSE:AJANTPHARM) Has Caught The Eye Of Investors

We Think Ajanta Pharma (NSE:AJANTPHARM) Can Manage Its Debt With Ease

Aug 23
We Think Ajanta Pharma (NSE:AJANTPHARM) Can Manage Its Debt With Ease

Ajanta Pharma Limited Just Recorded A 11% EPS Beat: Here's What Analysts Are Forecasting Next

Aug 04
Ajanta Pharma Limited Just Recorded A 11% EPS Beat: Here's What Analysts Are Forecasting Next

Some Confidence Is Lacking In Ajanta Pharma Limited's (NSE:AJANTPHARM) P/E

Aug 01
Some Confidence Is Lacking In Ajanta Pharma Limited's (NSE:AJANTPHARM) P/E

With EPS Growth And More, Ajanta Pharma (NSE:AJANTPHARM) Makes An Interesting Case

Jun 01
With EPS Growth And More, Ajanta Pharma (NSE:AJANTPHARM) Makes An Interesting Case

Ajanta Pharma Limited (NSE:AJANTPHARM) Analysts Are Pretty Bullish On The Stock After Recent Results

May 05
Ajanta Pharma Limited (NSE:AJANTPHARM) Analysts Are Pretty Bullish On The Stock After Recent Results

Ajanta Pharma Limited's (NSE:AJANTPHARM) Intrinsic Value Is Potentially 23% Below Its Share Price

Apr 05
Ajanta Pharma Limited's (NSE:AJANTPHARM) Intrinsic Value Is Potentially 23% Below Its Share Price

We Think Ajanta Pharma (NSE:AJANTPHARM) Can Manage Its Debt With Ease

Feb 23
We Think Ajanta Pharma (NSE:AJANTPHARM) Can Manage Its Debt With Ease

Ajanta Pharma Limited (NSE:AJANTPHARM) Investors Are Less Pessimistic Than Expected

Dec 23
Ajanta Pharma Limited (NSE:AJANTPHARM) Investors Are Less Pessimistic Than Expected

Ajanta Pharma (NSE:AJANTPHARM) Seems To Use Debt Quite Sensibly

Aug 26
Ajanta Pharma (NSE:AJANTPHARM) Seems To Use Debt Quite Sensibly

These 4 Measures Indicate That Ajanta Pharma (NSE:AJANTPHARM) Is Using Debt Reasonably Well

Feb 07
These 4 Measures Indicate That Ajanta Pharma (NSE:AJANTPHARM) Is Using Debt Reasonably Well

Here's Why Ajanta Pharma (NSE:AJANTPHARM) Has Caught The Eye Of Investors

Oct 24
Here's Why Ajanta Pharma (NSE:AJANTPHARM) Has Caught The Eye Of Investors

Estimating The Intrinsic Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Aug 25
Estimating The Intrinsic Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Is Now The Time To Put Ajanta Pharma (NSE:AJANTPHARM) On Your Watchlist?

Jul 19
Is Now The Time To Put Ajanta Pharma (NSE:AJANTPHARM) On Your Watchlist?

A Look At The Intrinsic Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Apr 28
A Look At The Intrinsic Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Ajanta Pharma (NSE:AJANTPHARM) Seems To Use Debt Quite Sensibly

Mar 14
Ajanta Pharma (NSE:AJANTPHARM) Seems To Use Debt Quite Sensibly

I Built A List Of Growing Companies And Ajanta Pharma (NSE:AJANTPHARM) Made The Cut

Feb 06
I Built A List Of Growing Companies And Ajanta Pharma (NSE:AJANTPHARM) Made The Cut

Estimating The Fair Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Dec 13
Estimating The Fair Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Ajanta Pharma (NSE:AJANTPHARM) Will Pay A Dividend Of ₹9.50

Oct 31
Ajanta Pharma (NSE:AJANTPHARM) Will Pay A Dividend Of ₹9.50

Here's Why We Think Ajanta Pharma (NSE:AJANTPHARM) Is Well Worth Watching

Sep 22
Here's Why We Think Ajanta Pharma (NSE:AJANTPHARM) Is Well Worth Watching

Is Ajanta Pharma Limited (NSE:AJANTPHARM) Trading At A 27% Discount?

Sep 08
Is Ajanta Pharma Limited (NSE:AJANTPHARM) Trading At A 27% Discount?

Does Ajanta Pharma (NSE:AJANTPHARM) Have A Healthy Balance Sheet?

Aug 26
Does Ajanta Pharma (NSE:AJANTPHARM) Have A Healthy Balance Sheet?

Here's Why Shareholders Will Not Be Complaining About Ajanta Pharma Limited's (NSE:AJANTPHARM) CEO Pay Packet

Jul 07
Here's Why Shareholders Will Not Be Complaining About Ajanta Pharma Limited's (NSE:AJANTPHARM) CEO Pay Packet

Should You Be Adding Ajanta Pharma (NSE:AJANTPHARM) To Your Watchlist Today?

Jun 14
Should You Be Adding Ajanta Pharma (NSE:AJANTPHARM) To Your Watchlist Today?

Is Ajanta Pharma Limited (NSE:AJANTPHARM) Trading At A 30% Discount?

May 15
Is Ajanta Pharma Limited (NSE:AJANTPHARM) Trading At A 30% Discount?

Ajanta Pharma Limited (NSE:AJANTPHARM) Vies For A Place In Your Dividend Portfolio: Here's Why

Apr 10
Ajanta Pharma Limited (NSE:AJANTPHARM) Vies For A Place In Your Dividend Portfolio: Here's Why

Ajanta Pharma Limited's (NSE:AJANTPHARM) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?

Mar 11
Ajanta Pharma Limited's (NSE:AJANTPHARM) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?

Does Ajanta Pharma (NSE:AJANTPHARM) Deserve A Spot On Your Watchlist?

Feb 24
Does Ajanta Pharma (NSE:AJANTPHARM) Deserve A Spot On Your Watchlist?

The Ajanta Pharma (NSE:AJANTPHARM) Share Price Is Up 56% And Shareholders Are Holding On

Jan 30
The Ajanta Pharma (NSE:AJANTPHARM) Share Price Is Up 56% And Shareholders Are Holding On

What Can We Make Of Ajanta Pharma's (NSE:AJANTPHARM) CEO Compensation?

Jan 18
What Can We Make Of Ajanta Pharma's (NSE:AJANTPHARM) CEO Compensation?

Estimating The Fair Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Jan 06
Estimating The Fair Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Rentabilidad de los accionistas

AJANTPHARMIN PharmaceuticalsMercado IN
7D3.5%0.5%0.5%
1Y51.2%42.5%27.5%

Rentabilidad vs. Industria: AJANTPHARM superó a la industria Indian Pharmaceuticals, que obtuvo un rendimiento del 42.5% el año pasado.

Rentabilidad vs. Mercado: AJANTPHARM superó al mercado Indian, que obtuvo un rendimiento del 27.5% el año pasado.

Volatilidad de los precios

Is AJANTPHARM's price volatile compared to industry and market?
AJANTPHARM volatility
AJANTPHARM Average Weekly Movement5.2%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.1%
10% most volatile stocks in IN Market9.1%
10% least volatile stocks in IN Market4.0%

Precio estable de las acciones: AJANTPHARM no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de AJANTPHARM (5%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
19738,073Yogesh Agrawalwww.ajantapharma.com

Ajanta Pharma Limited, una empresa de formulación de especialidades farmacéuticas, junto con sus filiales, desarrolla, fabrica y comercializa especialidades farmacéuticas en dosis acabadas. La empresa comercializa y presta servicio a varios segmentos terapéuticos, como cardiología, antidiabéticos, oftalmología, dermatología, tratamiento del dolor y áreas respiratorias. También suministra comprimidos, cápsulas, inyectables, inhaladores, pomadas, cremas y líquidos.

Resumen de fundamentos de Ajanta Pharma Limited

¿Cómo se comparan los beneficios e ingresos de Ajanta Pharma con su capitalización de mercado?
Estadísticas fundamentales de AJANTPHARM
Capitalización bursátil₹369.67b
Beneficios(TTM)₹8.75b
Ingresos (TTM)₹44.91b

42.2x

Ratio precio-beneficio (PE)

8.2x

Ratio precio-ventas (PS)

¿Está AJANTPHARM sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de AJANTPHARM
Ingresos₹44.91b
Coste de los ingresos₹11.43b
Beneficio bruto₹33.48b
Otros gastos₹24.73b
Beneficios₹8.75b

Últimos beneficios comunicados

Sep 30, 2024

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)70.06
Margen bruto74.56%
Margen de beneficio neto19.48%
Ratio deuda/patrimonio0.07%

¿Cómo se ha desempeñado AJANTPHARM a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

1.9%

Rentabilidad actual por dividendo

78%

Ratio de pagos
¿Cuándo hay que comprar AJANTPHARM para recibir un próximo dividendo?
fechas de dividendos de Ajanta Pharma
Fecha ex dividendoNov 06 2024
Fecha de pago de dividendosNov 27 2024
Días hasta ex dividendo19 days
Días hasta la fecha de pago de dividendos2 days